Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ossein-hydroxyapatite compound on wrist fracture healing time
2010-020973-18Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jan 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Wrist fracture comparing OSTEOGENON with Placebo (2 arms). Primary endpoint: Time to cortical bridging of three cortices. Started Jan 2011; status: completed.
02
Drugs
Osteogenon
03
Conditions
Wrist fracture
Beyond the preview
Go deeper on 2010-020973-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020973-18.